The greatly misunderstood erythropoietin resistance index and the case for a new responsiveness measure
出版年份 2016 全文链接
标题
The greatly misunderstood erythropoietin resistance index and the case for a new responsiveness measure
作者
关键词
-
出版物
Hemodialysis International
Volume 20, Issue 3, Pages 392-398
出版商
Wiley
发表日期
2016-02-04
DOI
10.1111/hdi.12407
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Assessment of hemoglobin responsiveness to epoetin alfa in patients on hemodialysis using a population pharmacokinetic pharmacodynamic model
- (2015) Liviawati Wu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Cardiovascular Toxicity of Epoetin-Alfa in Patients with Chronic Kidney Disease
- (2013) Peter A. McCullough et al. AMERICAN JOURNAL OF NEPHROLOGY
- Carbamylation of Serum Albumin and Erythropoietin Resistance in End Stage Kidney Disease
- (2013) S. Kalim et al. Clinical Journal of the American Society of Nephrology
- Control-Relevant Erythropoiesis Modeling in End-Stage Renal Disease
- (2013) Yossi Chait et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort study
- (2013) Tetsuya Ogawa et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Time-Dependent Resistance to Erythropoiesis-Stimulating Agent and Mortality in Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study
- (2013) Tetsuya Fujikawa et al. NEPHRON CLINICAL PRACTICE
- Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics
- (2013) David T Gilbertson et al. BMC Nephrology
- Confounding and Control of Confounding in Nonexperimental Studies of Medications in Patients With CKD
- (2012) Brian D. Bradbury et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Relationship between erythropoietin resistance index and left ventricular mass and function and cardiovascular events in patients on chronic hemodialysis
- (2011) Sungjin Chung et al. Hemodialysis International
- Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study
- (2011) V. Panichi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
- (2010) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients
- (2009) Kamyar Kalantar-Zadeh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL
- (2009) Brian D. Bradbury et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Greater Epoetin alfa Responsiveness Is Associated With Improved Survival in Hemodialysis Patients
- (2008) R. D. Kilpatrick et al. Clinical Journal of the American Society of Nephrology
- Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality
- (2008) Juan M. López-Gómez et al. KIDNEY INTERNATIONAL
- The effect of epoetin dose on hematocrit
- (2007) D. Cotter et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search